Holdings
Kynam Capital Management, LP
As of Jun 30, 2026, Kynam Capital Management, LP reported 24 positions worth US$1.54B. Largest: Celldex Therapeutics, Inc., Syndax Pharmaceuticals, Inc. and Vaxcyte, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Celldex Therapeutics, Inc. | 5.32M | US$198M | −518K | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 8.05M | US$176M | no change | Jun 30, 2026 |
| Vaxcyte, Inc. | 2.92M | US$170M | no change | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 3.67M | US$142M | −370K | Jun 30, 2026 |
| Vera Therapeutics, Inc. | 2.89M | US$124M | −508K | Jun 30, 2026 |
| Viridian Therapeutics, Inc. | 6.45M | US$119M | +4.11M | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 2M | US$114M | +431K | Jun 30, 2026 |
| Beam Therapeutics Inc. | 2.84M | US$97.5M | −841K | Jun 30, 2026 |
| Cytomx Therapeutics, Inc. | 21.7M | US$81.4M | +6.69M | Jun 30, 2026 |
| Relay Therapeutics, Inc. | 3.3M | US$61.7M | +1.88M | Jun 30, 2026 |